Predictors of antiproliferative effect of lanreotide autogel in advanced gastroenteropancreatic neuroendocrine neoplasms.

MLA

Laskaratos, Faidon-Marios, et al. “Predictors of Antiproliferative Effect of Lanreotide Autogel in Advanced Gastroenteropancreatic Neuroendocrine Neoplasms.” Endocrine (1355008X), vol. 67, no. 1, Jan. 2020, pp. 233–42. EBSCOhost, https://doi.org/10.1007/s12020-019-02086-6.

APA

Laskaratos, F.-M., Armeni, E., Shah, H., Megapanou, M., Papantoniou, D., Hayes, A. R., Navalkissoor, S., Gnanasegaran, G., von Stempel, C., Phillips, E., Furnace, M., Kamieniarz, L., Kousteni, M., Luong, T. V., Watkins, J., Mandair, D., Caplin, M., & Toumpanakis, C. (2020). Predictors of antiproliferative effect of lanreotide autogel in advanced gastroenteropancreatic neuroendocrine neoplasms. Endocrine (1355008X), 67(1), 233–242. https://doi.org/10.1007/s12020-019-02086-6

Chicago

Laskaratos, Faidon-Marios, Eleni Armeni, Heer Shah, Maria Megapanou, Dimitrios Papantoniou, Aimee R Hayes, Shaunak Navalkissoor, et al. 2020. “Predictors of Antiproliferative Effect of Lanreotide Autogel in Advanced Gastroenteropancreatic Neuroendocrine Neoplasms.” Endocrine (1355008X) 67 (1): 233–42. doi:10.1007/s12020-019-02086-6.